Literature DB >> 27431017

Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades.

Filomena Morisco1, Ilaria Loperto1, Tommaso Stroffolini2, Flavia Lucia Lombardo3, Valentina Cossiga1, Maria Guarino1, Alessia De Feo1, Nicola Caporaso1.   

Abstract

Data on the prevalence of HCV infection in Italy are often outdated and from non-urban populations. This study assessed the prevalence and risk factors for HCV infection in a large metropolitan area in southern Italy. A random 1:3 systematic sample of the adult general population of Naples was selected from three general practitioner patient registers in three different city districts. Socioeconomic indicators and risk factors for HCV infection were collected. Anti-HCV and HCV-RNA assays were performed. Logistic regression analysis was used to identify independent predictors of HCV infection. Of 1,500 randomly selected subjects, 1,315 (87.7%) participated in the study. Forty subjects (3.0%; 95%CI: 2.1-4.0) were anti-HCV-positive, with HCV-RNA detected by PCR in 31 (77.5%) of these. Anti-HCV prevalence increased with age, peaking (8.2%) in people born during the years 1945-1955. It was 1.7% in people residing in the better socioeconomic districts; but 5.7% in those residing in the district with lower socioeconomic status (P < 0.01). In multivariate analysis, age ≥60 years (OR 2.8, 95%CI: 1.3-6.1) and lower educational level (OR 3.6; 95%CI: 1.4-9.3), which is a proxy of low socioeconomic status, were the only independent predictors of the likelihood of anti-HCV positivity. Overall, 22.5% of anti-HCV positive subjects were previously unaware of their status. In the large city of Naples, infection with HCV is most common in people aged older than 60 years. Differences in socioeconomic conditions have played an important role in the spread of this infection. HCV positive subjects born during the years 1945-1955 are those who may benefit, to a greater extent, to be identified in order to receive the new effective therapy. J. Med. Virol. 89:291-297, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; hepatitis C; prevalence; risk factors

Mesh:

Substances:

Year:  2016        PMID: 27431017     DOI: 10.1002/jmv.24635

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.

Authors:  Luca Rinaldi; Maria Guarino; Alessandro Perrella; Pia Clara Pafundi; Giovanna Valente; Luca Fontanella; Riccardo Nevola; Barbara Guerrera; Natalina Iuliano; Michele Imparato; Alessio Trabucco; Ferdinando Carlo Sasso; Filomena Morisco; Antonio Ascione; Guido Piai; Luigi Elio Adinolfi
Journal:  Dig Dis Sci       Date:  2019-04-01       Impact factor: 3.199

2.  HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs.

Authors:  Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Chompoonut Auphimai; Nipaporn Siripon; Sirapa Klinfueng; Pisit Tangkijvanich; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PeerJ       Date:  2017-11-06       Impact factor: 2.984

3.  Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.

Authors:  Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Nipaporn Siripon; Nawarat Posuwan; Chompoonut Auphimai; Sirapa Klinfueng; Napha Thaneskongtong; Viboonsak Vuthitanachot; Supapith Saiyatha; Chaiwat Thongmai; Sarawut Suwanpatoomlerd; Saowakon Sochoo; Natnada Pongsuwan; Kittiyod Poovorawan; Pisit Tangkijvanich; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

4.  Prevalence of hepatitis C in the adult population of Bulgaria: a pilot study.

Authors:  Ida Sperle; Stine Nielsen; Martyna Gassowski; Zlatina Naneva; Tanya Perchemlieva; Andrew Amato-Gauci; Matthias An der Heiden; Viviane Bremer; Elitsa Golkocheva-Markova; Kristiyan Hristov; Elena Kaneva; Yanita Simeonova; Tencho Tenev; Tonka Varleva; Erika Duffell; Ruth Zimmermann
Journal:  BMC Res Notes       Date:  2020-07-07

5.  Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019).

Authors:  Ida Sperle; Stine Nielsen; Viviane Bremer; Martyna Gassowski; Henrikki Brummer-Korvenkontio; Roberto Bruni; Anna Rita Ciccaglione; Elena Kaneva; Kirsi Liitsola; Zlatina Naneva; Tanya Perchemlieva; Enea Spada; Salla E Toikkanen; Andrew J Amato-Gauci; Erika Duffell; Ruth Zimmermann
Journal:  Front Public Health       Date:  2021-05-28

6.  High Rates of Hidden HCV Infections among Hospitalized Patients Aged 55-85.

Authors:  Annarita Valeria Piazzolla; Giulia Paroni; Francesca Bazzocchi; Mauro Cassese; Antonio Cisternino; Luigi Ciuffreda; Franco Gorgoglione; Leonardo Gorgoglione; Vincenzo Palazzo; Natale Sciannamè; Marco Taurchini; Pasquale Vaira; Giovanna Cocomazzi; Maria Maddalena Squillante; Filippo Aucella; Nicola Cascavilla; Salvatore De Cosmo; Michelantonio Fania; Antonio Greco; Antonio Laborante; Maurizio Leone; Evaristo Maiello; Mauro Salvatori; Lazzaro Di Mauro; Alessandra Mangia
Journal:  Pathogens       Date:  2021-06-03

7.  Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.

Authors:  Pierluca Piselli; Diego Serraino; Mario Fusco; Enrico Girardi; Angelo Pirozzi; Federica Toffolutti; Claudia Cimaglia; Martina Taborelli
Journal:  BMC Infect Dis       Date:  2021-07-08       Impact factor: 3.090

8.  Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.

Authors:  Alberto Ferrarese; Giacomo Germani; Martina Gambato; Francesco Paolo Russo; Marco Senzolo; Alberto Zanetto; Sarah Shalaby; Umberto Cillo; Giacomo Zanus; Paolo Angeli; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

9.  Estimation of the number of HCV-positive patients in Italy.

Authors:  Ivan Gardini; Marco Bartoli; Massimiliano Conforti; Francesco Saverio Mennini; Andrea Marcellusi
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

10.  Study of Hepatitis C Virus Detection Assays.

Authors:  Mithaq Sabeeh Khudur Al-Nassary; Batool Mutar Mahdi
Journal:  Ann Med Surg (Lond)       Date:  2018-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.